Jung B, Woo S, Kim S, Kim Y
BMB Rep. 2024; 57(2):104-109.
PMID: 38303562
PMC: 10910092.
Castro-Guijarro A, Vanderhoeven F, Mondaca J, Redondo A, Zoppino F, Fernandez-Munoz J
Cells. 2022; 11(19).
PMID: 36230951
PMC: 9564078.
DOI: 10.3390/cells11192988.
Chakraborty M, Bhattacharyya S, Roy S, Bhattacharya I, Das R, Mukherjee A
J Biol Chem. 2021; 296:100449.
PMID: 33617879
PMC: 7946438.
DOI: 10.1016/j.jbc.2021.100449.
Worthmuller J, Ruegg C
Int J Mol Sci. 2020; 21(23).
PMID: 33266025
PMC: 7730291.
DOI: 10.3390/ijms21239107.
Alowaidi F, Hashimi S, Alqurashi N, Wood S, Wei M
Oncol Lett. 2019; 18(3):3399-3406.
PMID: 31452820
PMC: 6676405.
DOI: 10.3892/ol.2019.10626.
Resistance to Src inhibition alters the BRAF-mutant tumor secretome to promote an invasive phenotype and therapeutic escape through a FAK>p130Cas>c-Jun signaling axis.
Kessler B, Mishall K, Kellett M, Clark E, Pugazhenthi U, Pozdeyev N
Oncogene. 2018; 38(14):2565-2579.
PMID: 30531837
PMC: 6450711.
DOI: 10.1038/s41388-018-0617-1.
Inhibition of PTP1B disrupts cell-cell adhesion and induces anoikis in breast epithelial cells.
Hilmarsdottir B, Briem E, Halldorsson S, Kricker J, Ingthorsson S, Gustafsdottir S
Cell Death Dis. 2017; 8(5):e2769.
PMID: 28492548
PMC: 5520702.
DOI: 10.1038/cddis.2017.177.
Neutral endopeptidase (NEP) is differentially involved in biological activities and cell signaling of colon cancer cell lines derived from various stages of tumor development.
Mizerska-Kowalska M, Bojarska-Junak A, Jakubowicz-Gil J, Kandefer-Szerszen M
Tumour Biol. 2016; 37(10):13355-13368.
PMID: 27460083
PMC: 5097095.
DOI: 10.1007/s13277-016-5248-y.
Cbl-b promotes cell detachment via ubiquitination of focal adhesion kinase.
Fan Y, Qu X, Ma Y, Liu Y, Hu X
Oncol Lett. 2016; 12(2):1113-1118.
PMID: 27446403
PMC: 4950184.
DOI: 10.3892/ol.2016.4730.
FAK and paxillin, two potential targets in pancreatic cancer.
Kanteti R, Batra S, Lennon F, Salgia R
Oncotarget. 2016; 7(21):31586-601.
PMID: 26980710
PMC: 5058780.
DOI: 10.18632/oncotarget.8040.
Tumor Necrosis Factor-α (TNFα)-induced Ceramide Generation via Ceramide Synthases Regulates Loss of Focal Adhesion Kinase (FAK) and Programmed Cell Death.
Hernandez-Corbacho M, Canals D, Adada M, Liu M, Senkal C, Yi J
J Biol Chem. 2015; 290(42):25356-73.
PMID: 26318452
PMC: 4646185.
DOI: 10.1074/jbc.M115.658658.
Identification of genes associated with laryngeal squamous cell carcinoma samples based on bioinformatic analysis.
Yang B, Bao X
Mol Med Rep. 2015; 12(3):3386-3392.
PMID: 25997441
PMC: 4526082.
DOI: 10.3892/mmr.2015.3794.
Focal adhesion kinase and p53 synergistically decrease neuroblastoma cell survival.
Gillory L, Stewart J, Megison M, Waters A, Beierle E
J Surg Res. 2015; 196(2):339-49.
PMID: 25862488
PMC: 4442704.
DOI: 10.1016/j.jss.2015.03.021.
Targeted inhibition of FAK, PYK2 and BCL-XL synergistically enhances apoptosis in ovarian clear cell carcinoma cell lines.
Yoon H, Choi Y, Song J, Do I, Kang S, Ko Y
PLoS One. 2014; 9(2):e88587.
PMID: 24523919
PMC: 3921183.
DOI: 10.1371/journal.pone.0088587.
Targeting FAK in human cancer: from finding to first clinical trials.
Golubovskaya V
Front Biosci (Landmark Ed). 2014; 19(4):687-706.
PMID: 24389213
PMC: 3952878.
DOI: 10.2741/4236.
Focal adhesion kinase autophosphorylation inhibition decreases colon cancer cell growth and enhances the efficacy of chemotherapy.
Heffler M, Golubovskaya V, Dunn K, Cance W
Cancer Biol Ther. 2013; 14(8):761-72.
PMID: 23792569
PMC: 3841216.
DOI: 10.4161/cbt.25185.
The detergent-soluble cytoplasmic pool of survivin suppresses anoikis and its expression is associated with metastatic disease of human colon cancer.
Hori M, Miki T, Okamoto M, Yazama F, Konishi H, Kaneko H
PLoS One. 2013; 8(2):e55710.
PMID: 23405201
PMC: 3565976.
DOI: 10.1371/journal.pone.0055710.
Involvement of Src in the Adaptation of Cancer Cells under Microenvironmental Stresses.
Hasan A, Ijiri T, Sato K
J Signal Transduct. 2012; 2012:483796.
PMID: 22988500
PMC: 3439988.
DOI: 10.1155/2012/483796.
FAK, CD44v6, c-Met and EGFR in colorectal cancer parameters: tumour progression, metastasis, patient survival and receptor crosstalk.
Garouniatis A, Zizi-Sermpetzoglou A, Rizos S, Kostakis A, Nikiteas N, Papavassiliou A
Int J Colorectal Dis. 2012; 28(1):9-18.
PMID: 22733437
DOI: 10.1007/s00384-012-1520-9.
A small molecule focal adhesion kinase (FAK) inhibitor, targeting Y397 site: 1-(2-hydroxyethyl)-3, 5, 7-triaza-1-azoniatricyclo [3.3.1.1(3,7)]decane; bromide effectively inhibits FAK autophosphorylation activity and decreases cancer cell viability,....
Golubovskaya V, Figel S, Ho B, Johnson C, Yemma M, Huang G
Carcinogenesis. 2012; 33(5):1004-13.
PMID: 22402131
PMC: 3334519.
DOI: 10.1093/carcin/bgs120.